Hospice News May 24, 2024
The nation’s publicly traded hospice companies are primed for more acquisitions after a 2023 slump, fueled by census and growth.
Transaction volume declined in the hospice and home-based care space in 2023, following the two record-breaking prior years. Many expect a rebound in 2024, and stirrings in the public company space signal that may come to fruition.
Case in point, VITAS Healthcare, a subsidiary of Chemed Corp. (NYSE: CHE), made its first acquisition in several years with the $85 million acquisition of Covenant Health and Community Services’ hospice operations and one assisted living facility location.
Now, the company may be poised for more deals, Michael Witzeman, vice president, CFO and controller at Chemed said during the Bank of America Securities...
Today's Sponsors
Today's Sponsor